✦ LIBER ✦

Orphan drugs: European biotechnology waits for EC act

✍ Scribed by Davidson, Sylvia

Book ID: 109902991
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 426 KB
Volume: 14
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0496-419b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experimental use and the orphan drug act

Experimental use and the orphan drug act: A biotechnology conundrum

✍ Koivuniemi, Paul J. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 386 KB

Discovery Laboratories: European orphan

Discovery Laboratories: European orphan drug for Surfaxin

📂 Article 📅 2002 🏛 Elsevier Science ⚖ 31 KB

scheduled to start up in 1H 2006. It will produce 85,000 tonnes/y ethoxylates, 20,000 tonnes/y of methyl diethanolamine and di-methyl ethanolamine, 150,000 tonnes/y of ethylene oxide, 100,000 tonnes/y of ethanolamines, 50,000 tonnes/y of methylamine, 50,000 tonnes/y of dimethyl formamide and 15,000

The Impact of the Orphan Drug Act on the

The Impact of the Orphan Drug Act on the Development and Advancement of Neurological Products for Rare Diseases: A Descriptive Review

✍ Burke, K A; Freeman, S N; Imoisili, M A; Coté, T R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB